Randomised, double-blind, placebo-controlled single ascending dose study investigating the safety, tolerability, pharmacokinetic and pharmacodynamic properties of the research medication in healthy young and elderly men, and open-label three-period crossover food interaction study of the research medication in healthy elderly me
Completed
- Conditions
- Parkinsons disease10028037
- Registration Number
- NL-OMON36711
- Lead Sponsor
- undbeck
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 171
Inclusion Criteria
Healthy Male
Exclusion Criteria
Clinical significant abnormalities at medical research
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Safety and tolerability</p><br>
- Secondary Outcome Measures
Name Time Method <p>Pharmacokinetics and pharmacodynamics</p><br>